Saturday 17 October 2026
Export AMWL’s income statement to Excel — free account
American Well Corporation
AMWL Healthcare Health Information Services
American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024. In the quarter to June 2026, revenue fell 26.6%, EPS grew 52.4% and free cash flow grew 266.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
11.68
0.70
−5.65%
Follow AMWL
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 5 | 3 | 4 | 4 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(7.95) | (6.26) | (4.56) | 2.22 | 4.53 | 11.44 | — | — | — |
P/S ratio |
0.32 | 0.43 | 1.59 | 2.79 | 6.07 | 10.23 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(16.00) | (12.18) | (9.04) | 6.85 | 7.61 | 12.27 | (2.45) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
(3.29) | (3.25) | (7.12) | (2.67) | (2.03) | (2.42) | — | — | — |
P/Operating CF |
(4.54) | (8.09) | (9.91) | (21.51) | (34.16) | (102.27) | (38.99) | (38.99) | — |
P/B ratio |
0.32 | 0.34 | 0.86 | 0.71 | 1.22 | 2.01 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.43 | 0.51 | 1.15 | 1.51 | 2.31 | 2.52 | 0.00 | 0.00 | — |
EV/Sales |
(0.42) | (0.47) | 0.15 | 0.85 | 3.12 | 5.98 | 0.00 | 0.00 | — |
EV/EBITDA |
1.53 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
1.57 | 0.94 | (0.27) | (1.22) | (5.57) | (13.04) | (6.08) | (6.08) | — |
EV/FCF |
1.57 | 0.84 | (0.25) | (1.16) | (5.55) | (12.66) | (5.92) | (5.92) | — |
Quick Ratio |
3.17 | 2.70 | 4.54 | 5.23 | 5.63 | 8.99 | 1.97 | 3.32 | — |
Current Ratio |
3.37 | 2.85 | 4.79 | 5.49 | 5.84 | 9.20 | 2.10 | 3.39 | — |
Net Debt/EBITDA |
2.69 | 1.26 | 1.68 | 2.18 | 4.65 | 4.85 | 2.09 | 5.37 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.66 | 0.50 | 0.29 | 0.21 | 0.18 | 0.26 | 0.60 | 0.00 | — |
Operating CF/Net income |
0.69 | 0.61 | 0.22 | 0.71 | 0.80 | 0.50 | 0.94 | 1.41 | — |
Capex/Depreciation |
0.00 | (0.42) | (0.03) | (0.37) | (0.03) | (0.27) | (0.14) | (0.29) | — |
| (33.93%) | (52.27%) | (86.34%) | (23.07%) | (14.07%) | (46.50%) | 34.00% | 19.55% | — | |
| (25.19%) | (40.59%) | (74.72%) | (20.31%) | (12.49%) | (23.92%) | (34.88%) | 0.00% | — | |
ROIC |
(100.51%) | (154.63%) | (400.00%) | (31.62%) | (21.76%) | (69.84%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(55.10%) | (100.99%) | (189.46%) | (52.66%) | (25.63%) | (22.53%) | (72.89%) | (24.73%) | — |
Average Days of Receivables |
72.75 | 103.15 | 76.29 | 76.86 | 74.18 | 67.41 | 80.25 | 99.29 | — |
Research and Development Expense of Revenue |
29.22% | 33.84% | 40.85% | 49.96% | 42.17% | 34.42% | 36.24% | 31.83% | — |
Selling, General and Administrative Expense of Revenue |
52.67% | 77.62% | 82.26% | 82.25% | 63.60% | 90.25% | 68.44% | 60.42% | — |
Intangible Assets out of Total Assets |
0.20 | 0.23 | 0.20 | 0.47 | 0.41 | 0.18 | 0.51 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
8.83% | 18.69% | 27.89% | 28.43% | 18.42% | 48.26% | 8.15% | 6.73% | — |
Graham Net Nets |
2.17 | 1.81 | 0.83 | 0.64 | 0.42 | 0.39 | 0.20 | 0.20 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(121.18%) | (193.10%) | (165.52%) | (34.75%) | (11.42%) | (9.02%) | (2.56%) | (2.56%) | — |
Free Cash Flow Yield |
(83.73%) | (131.09%) | (39.69%) | (26.22%) | (9.26%) | (4.62%) | (14.29%) | (14.29%) | — |
Revenue per Share |
15.54 | 16.96 | 18.23 | 20.22 | 19.90 | 49.53 | 72.37 | 56.16 | — |
Operating CF per Share |
(4.11) | (8.49) | (10.44) | (14.03) | (11.14) | (22.71) | (39.81) | (36.47) | — |
Capex per Share |
0.00 | (1.01) | (1.07) | (0.76) | (0.04) | (0.67) | (0.65) | (0.94) | — |
Free Cash Flow per Share |
(4.11) | (9.50) | (11.51) | (14.79) | (11.19) | (23.38) | (40.46) | (37.41) | — |
Cash per Share |
11.36 | 15.22 | 26.18 | 39.28 | 58.76 | 210.55 | 86.35 | 128.62 | — |
Shareholders Equity per Share |
15.44 | 21.08 | 33.79 | 79.06 | 99.25 | 251.65 | (136.54) | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
15.44 | 21.08 | 33.79 | 79.06 | 99.25 | 251.65 | (136.54) | 0.00 | — |
Free Cash Flow |
(65.97) | (142.56) | (163.59) | (202.77) | (142.10) | (115.78) | (83.23) | (75.92) | — |
Working Capital |
173.47 | 205.73 | 355.79 | 512.56 | 685.67 | 992.31 | 116.95 | 210.00 | — |
Capital Expenditures |
(0.02) | (15.22) | (15.25) | (10.45) | (0.56) | (3.32) | (1.34) | (1.91) | — |
Net Current Asset Value |
170.68 | 197.27 | 340.06 | 492.91 | 642.34 | 982.84 | (557.22) | 298.00 | — |
EV/EBIT |
0.98 | 0.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.06 | 0.06 | 0.04 | 0.00 | 0.01 | 0.01 | 0.02 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
167.12 | 95.45 | 822.87 | 28.13 | 8.41 | 3.24 | 3.58 | 2.17 | — |
Cash ROIC |
(15.34%) | (26.18%) | (19.20%) | (12.50%) | (7.08%) | (5.06%) | 80.62% | (29.09%) | — |
Accounts Receivable Turnover |
4.10 | 4.04 | 4.60 | 5.05 | 5.23 | 6.29 | 4.67 | 3.56 | — |
Accounts Payable Turnover |
34.95 | 31.46 | 27.15 | 16.55 | 16.54 | 25.49 | 15.23 | 10.66 | — |
Inventory Turnover |
57.59 | 32.68 | 21.35 | 19.72 | 17.83 | 25.64 | 26.20 | 19.54 | — |
Average Days of Payables |
5.17 | 11.78 | 10.81 | 16.46 | 29.88 | 13.50 | 29.68 | 24.91 | — |
Days of Inventory on Hand |
3.72 | 6.71 | 14.78 | 19.88 | 18.51 | 21.25 | 14.17 | 18.68 | — |
Average Receivables |
60.79 | 63.02 | 56.26 | 54.87 | 48.34 | 39.01 | 31.87 | 32.00 | — |
Average Payables |
3.33 | 4.94 | 6.05 | 9.70 | 8.98 | 6.15 | 5.25 | 5.50 | — |
Average Inventory |
2.02 | 4.76 | 7.69 | 8.13 | 8.33 | 6.12 | 3.05 | 3.00 | — |
Average Assets |
379.88 | 512.84 | 903.63 | 1,331.70 | 1,411.24 | 938.26 | 249.94 | 0.00 | — |
Average Common Equity |
282.02 | 398.22 | 782.02 | 1,172.36 | 1,253.54 | 482.67 | (256.43) | (269.50) | — |
Columns are period end dates